(Q33916410)

30 July 2017

1 reference

title

Episomal vectors for gene expression in mammalian cells (English)

1 reference

30 July 2017

K Van Craenenbroeck

1

1 reference

30 July 2017

P Vanhoenacker

series ordinal

2

1 reference

30 July 2017

G Haegeman

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

30 July 2017

1 reference

30 July 2017

267

1 reference

30 July 2017

18

1 reference

30 July 2017

5665-5678

1 reference

30 July 2017

Receptor-based assays.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Episome-generated N-myc antisense RNA restricts the differentiation potential of primitive neuroectodermal cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Receptor cloning and heterologous expression--towards a new tool for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Integration of foreign DNA and its consequences in mammalian systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Repeat-induced gene silencing in mammals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Efficient cDNA cloning by direct phenotypic correction of a mutant human cell line (HPRT−) using an Epstein - Barr virus-derived cDNA expression vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Extremely efficient gene transfection into lympho-hematopoietic cell lines by Epstein-Barr virus-based vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Epstein-Barr virus shuttle vector for stable episomal replication of cDNA expression libraries in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

A system utilizing Epstein-Barr virus-based expression vectors for the functional cloning of human fibroblast growth regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Developments in expression cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

pZ402, an improved SV40-based shuttle vector containing a T-antigen mutant unable to interact with wild-type p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

The potential of extrachromosomal replicating vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Safety-modified episomal vectors for human gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Expression cloning of a human DNA repair gene involved in xeroderma pigmentosum group C

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Gene therapy -- promises, problems and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

The primary structure and genetic organization of the bovine papillomavirus type 1 genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

New human papovavirus (B.K.) isolated from urine after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Nucleotide sequence of the DNA replication origin for human papovavirus BKV: sequence and structural homology with SV40

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

The genome of human papovavirus BKV

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Transactivation of BKV and SV40 early promoters by BKV and SV40 T-antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

The late promoter of the human papovavirus BK is contained within the early promoter enhancer region

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

The initiation of simian virus 40 DNA replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

BK Virus-Plasmid Expression Vector That Persists Episomally in Human Cells and Shuttles into Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Factors affecting amplification of BK virus episomal vectors in human cells. Brief report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

New BK virus episomal vector for complementary DNA expression in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Constitutive expression in human cells of herpes simplex virus type 1 glycoprotein B gene cloned in an episomal eukaryotic vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

A novel BK virus-based episomal vector for expression of foreign genes in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Efficient episomal expression vector for human transitional carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Systemic gene therapy: biodistribution and long-term expression of a transgene in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Molecular integrity and usefulness of episomal expression vectors derived from BK and Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Rolling-circle replication of a high-copy BPV-1 plasmid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Induction of structural changes in the bovine papillomavirus type 1 origin of replication by the viral E1 and E2 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Characterization of the bovine papilloma virus plasmid maintenance sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Replication of plasmids derived from bovine papilloma virus type 1 and Epstein-Barr virus in cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Bovine papilloma virus (BPV)-encoded E1 protein contains multiple activities required for BPV DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

The cellular DNA polymerase alpha-primase is required for papillomavirus DNA replication and associates with the viral E1 helicase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Modulation of bovine papillomavirus DNA replication by phosphorylation of the viral E1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Segregation of viral plasmids depends on tethering to chromosomes and is regulated by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

The bovine papilloma virus E1 protein has ATPase activity essential to viral DNA replication and efficient transformation in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

In vitro tumorigenic transformation by a defined sub-genomic fragment of bovine papilloma virus DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Bovine Papilloma Virus Deoxyribonucleic Acid: a Novel Eucaryotic Cloning Vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Regulation of a metallothionein-growth hormone hybrid gene in bovine papilloma virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Complementation of a vesicular stomatitis virus glycoprotein G mutant with wild-type protein expressed from either a bovine papilloma virus or a vaccinia virus vector system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Replication of bovine papillomavirus vectors in murine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Construction of a novel bovine papillomavirus vector without detectable transforming activity suitable for gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Epstein-Barr virus vectors for gene expression and transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Epstein-Barr virus strategy in normal and neoplastic B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Viral latency and transformation: the strategy of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Chromatin structure of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Interactions of Epstein-Barr virus origins of replication with nuclear matrix in the latent and in the lytic phases of viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

The cellular proteins that bind specifically to the Epstein-Barr virus origin of plasmid DNA replication belong to a gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Mechanistic studies on the DNA linking activity of Epstein-Barr nuclear antigen 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Role of EBNA-1 in arresting replication forks at the Epstein-Barr virus oriP family of tandem repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Isolation of human sequences that replicate autonomously in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Initiation of latent DNA replication in the Epstein-Barr virus genome can occur at sites other than the genetically defined origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

The minimal replicator of Epstein-Barr virus oriP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Studies on the mechanism of DNA linking by Epstein-Barr virus nuclear antigen 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

The linking regions of EBNA1 are essential for its support of replication and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Epstein-Barr virus genomes in lymphoid cells: activation in mitosis and chromosomal location

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Utilization of an Epstein-Barr virus replicon as a eukaryotic expression vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Isolation of a clone which induces expression of the gene encoding the human tumor necrosis factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

An expression system for mammalian amino acid transporters using a stably maintained episomal vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Human recombinant alpha1(V) collagen chain. Homotrimeric assembly and subsequent processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Efficient gene transduction by Epstein-Barr-virus-based vectors coupled with cationic liposome and HVJ-liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Construction of an EBNA-producing line of well-differentiated human hepatoma cells and of appropriate Epstein-Barr virus-based shuttle vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Improved expression cloning using reporter genes and Epstein-Barr virus ori-containing vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Combinatorial gene expression using multiple episomal vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Rapid generation of stable cell lines expressing corticotropin-releasing hormone receptor for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Differences in human cell lines to support stable replication of Epstein-Barr virus-based vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Gene transfer in vitro and in vivo with Epstein-Barr virus-based episomal vector results in markedly high transient expression in rodent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Epstein-Barr virus-based vectors that replicate in rodent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Epstein-Barr-based episomal chromosomes shuttle 100 kb of self-replicating circular human DNA in mouse cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

The use of Epstein-Barr virus-based shuttle vectors in rat PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor I

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Long-term replication of Epstein-Barr virus-derived episomal vectors in the rodent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Selective extraction of polyoma DNA from infected mouse cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

High-frequency transformation of human repair-deficient cell lines by an Epstein-Barr virus-based cDNA expression vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Human artificial episomal chromosomes for cloning large DNA fragments in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Transgenic mice containing a human heavy chain immunoglobulin gene fragment cloned in a yeast artificial chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Analysis of a YAC with human telomeres and oriP from epstein-barr virus in yeast and 293 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

A system for shuttling 200-kb BAC/PAC clones into human cells: stable extrachromosomal persistence and long-term ectopic gene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Long-term stability of large insert genomic DNA episomal shuttle vectors in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Synthetic DNA delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Gene therapy: the first decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Viral vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Epstein-Barr virus vectors for gene delivery to B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

A strategy for specific targeting of therapeutic agents to tumour cells of virus-associated cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

A reporter system using a flow cytometer to detect promoter/enhancer activity in lymphoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein-Barr virus (EBV)-based mini-chromosome vectors in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Transient gene expression control: effects of transfected DNA stability and trans-activation by viral early proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Mechanisms of transcriptional regulation of cellular genes by SV40 large T- and small T-antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Chromosomal aberrations induced by BK virus T antigen in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

New host cell system for regulated simian virus 40 DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Cell-surface expression of influenza haemagglutinin from a cloned DNA copy of the RNA gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

High level transient gene expression in human lymphoid cells by SV40 large T antigen boost

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

A two-plasmid system for transient expression of cDNAs in primate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Simian virus 40 (SV40) large T antigen-dependent amplification of an Epstein-Barr virus-SV40 hybrid shuttle vector integrated into the human HeLa cell genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

A novel herpesvirus amplicon system for in vivo gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

The Epstein-Barr virus nuclear antigen (BamHI K antigen) is a single-stranded DNA binding phosphoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Analysis of the early regulatory region of the human papovavirus BK

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Improved EBV shuttle vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Successful transfer of ADA gene in vitro into human peripheral blood CD34+ cells by transfecting EBV-based episomal vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

Inhibition of protein kinase C alpha expression by antisense RNA in transfected Jurkat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2000.01645.X

10.1046/J.1432-1327.2000.01645.X

21 January 2018

Identifiers

DOI

1 reference

release_vtpgr7lhlvfgrhvebnxil7je4e

30 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vtpgr7lhlvfgrhvebnxil7je4e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference